Kodiak Sciences Inc.
KODCIK 0001468748 · last filing Jul 2, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
No trades dated in this window. Older or late-filed transactions appear in the filing tape below.
Filing tape
Filed Thu, Jul 2, 2026
- ±0
Dahiyat Bassil I — Director
- Granted17,731Stock Option (Right to Buy)→ 17,731 held
- ±0
Bancroft Charles A — Director
- Granted17,731Stock Option (Right to Buy)→ 17,731 held
- ±0
Levy Richard S — Director
- Granted17,731Stock Option (Right to Buy)→ 17,731 held
- ±0
Yang Taiyin — Director
- Granted17,731Stock Option (Right to Buy)→ 17,731 held
- ±0
Baker Bros. Advisors LP +5 — Director · 10% owner
- Granted17,731Non-Qualified Stock Options (right to buy)→ 17,731 held
- Granted17,731Non-Qualified Stock Options (right to buy)→ 17,731 held
- ±0
Profusek Robert — Director
- Granted17,731Stock Option (Right to Buy)→ 17,731 held
Insiders on this tape
- Dahiyat Bassil IDirector
- Bancroft Charles ADirector
- Levy Richard SDirector
- Yang TaiyinDirector
- Baker Bros. Advisors LPDirector · 10% owner
- 667, L.p.Director · 10% owner
- Baker Bros. Advisors (GP) LLCDirector · 10% owner
- Baker Brothers Life Sciences LPDirector · 10% owner
- Baker FelixDirector · 10% owner
- Baker JulianDirector · 10% owner
- Profusek RobertDirector
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.